Evidence map›Paper›PMID 35630852›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Prussian Blue Nanozymes with Enhanced Catalytic Activity: Size Tuning and Application in ELISA-like Immunoassay.

Pavel Khramtsov, Maria Kropaneva, Artem Minin, Maria Bochkova, Valeria Timganova, Andrey Maximov, Alexey Puzik, Svetlana Zamorina, Mikhail Rayev

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Biomedical Applications of Nanozymes: An Enzymology Perspective.Angewandte Chemie (International ed. in English) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pavel KhramtsovFaculty of Biology, Perm State University, 614068 Perm, Russia.ORCID 0000-0002-1707-4423
Maria KropanevaFaculty of Biology, Perm State University, 614068 Perm, Russia.
Artem MininLab of Applied Magnetism, M.N. Mikheev Institute of Metal Physics of the UB RAS, 620108 Yekaterinburg, Russia.ORCID 0000-0003-3305-3195
Maria BochkovaFaculty of Biology, Perm State University, 614068 Perm, Russia.
Valeria TimganovaLab of Ecological Immunology, Institute of Ecology and Genetics of Microorganisms, 614081 Perm, Russia.ORCID 0000-0003-4581-1969
Andrey MaximovDepartment of Analytical Chemistry and Expertise, Faculty of Chemistry, Perm State University, 614068 Perm, Russia.
Alexey PuzikDepartment of Mineralogy and Petrography, Faculty of Geology, Perm State University, 614068 Perm, Russia.
Svetlana ZamorinaFaculty of Biology, Perm State University, 614068 Perm, Russia.
Mikhail RayevFaculty of Biology, Perm State University, 614068 Perm, Russia.

Funding

Russian Science Foundation 20-75-00029
6 · The paper itself

Abstract

Prussian blue nanozymes possessing peroxidase-like activity gather significant attention as alternatives to natural enzymes in therapy, biosensing, and environmental remediation. Recently, Prussian blue nanoparticles with enhanced catalytic activity prepared by reduction of FeCl

Indexed as

antibodyconjugategelatinimmunoassaynanozymeperoxidaseprostate-specific antigenprussian bluestreptavidintetanus

Identifiers

PMID35630852
PMCPMC9147909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.